Breadcrumb
Home > EventsEvents
Upcoming events
4 Jun 2026 - 6 Jun 2026
2026 Research-for-Cure Academy
The academy awards fellowships to up to 15 applicants to participate in a series of interactive workshops
View details View details
4 Jun 2026
Integrating HIV prevention into public health systems while protecting equitable access
Join a webinar on countries integrating HIV prevention into healthcare systems, building sustainable, equitable responses
View details View details
26 Jul 2026 - 31 Jul 2026
The 26th International AIDS Conference
AIDS 2026, the 26th International AIDS Conference, taking place in Rio de Janeiro, Brazil, and virtually on 26-31 July 2026.
View details View details
26 Jul 2026
AIDS 2026 pre-conference, "Advancing HIV prevention science and access"
To accelerate progress in HIV prevention, it is increasingly important to translate emerging scientific innovations into real-world impact. Recent breakthroughs, including the approval of lenacapavir, the first twice-yearly injectable PrEP, alongside advances in broadly neutralizing antibodies, mRNA-based platforms and immunogen design, are expanding the range of prevention options. However, these advances will have impact only if they are affordable, accessible and delivered at scale, particularly in low- and middle-income settings and for people most affected by HIV.This pre-conference programme will examine the latest advances across basic, translational, clinical and implementation science and explore how emerging discoveries can inform equitable, real-world prevention strategies. Capitalizing on AIDS 2026 taking place in Rio de Janeiro, Brazil, the programme will engage regional scientific stakeholders and spotlight innovations from Latin America and beyond.Supported by View session outline
View details View details
26 Jul 2026
AIDS 2026 HIV cure pre-conference, "HIV cure without borders: Science, community and Latin America and Caribbean perspectives"
The pre-conference will strengthen community and clinical understanding of HIV cure research priorities.
View details View details
26 Jul 2026
AIDS 2026 pre-conference: 12th Symposium on Children and Adolescents with Perinatal HIV Exposure
As of 2024, an estimated 16 million children under 15 years of age had been perinatally exposed to HIV globally and were born HIV-free. An expanding body of evidence shows that these children experience a higher likelihood of infectious morbidity, mortality, impaired growth and suboptimal neurodevelopmental and cognitive outcomes than peers born to mothers without HIV, with the aetiology of these adverse outcomes reflecting an interplay of biological, social and structural factors.Optimizing the health and well-being of children and adolescents with perinatal HIV exposure requires an understanding of their unique exposures, vulnerabilities and needs. Rigorous, multidisciplinary research is essential to identify mechanisms responsible for the increased likelihood of poor health and developmental outcomes. The development of screening tools is important, particularly in settings where health resources are constrained, to identify who would benefit most from timely interventions. Equally important is the design, testing and implementation of evidence-based interventions, policies and programmes tailored to the needs of this population.With the theme, Learning from successes and challenges of other paediatric programmes to optimize outcomes of children and adolescents with perinatal HIV exposure, the symposium will:Present the latest scientific evidence on health, development and well-being of children and adolescents with perinatal HIV exposure.Address key policy and programme priorities.Foster networking and collaboration among early-career researchers, policymakers, programme managers and advocates.The 12th Symposium builds on over a decade of meetings dedicated to the health and well-being of children and adolescents born HIV-free to women living with HIV. It will be comprised of three sessions: Session 1: Optimizing development after perinatal HIV exposure Session 2: Identifying risk and supporting families: Lessons from other programmes Session 3: Long-term follow-up: From data to actionThe symposium is organized by the Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) of IAS – the International AIDS Society – in collaboration with Penta - Child Health Research, Mass General Brigham, Paediatric-Adolescent Treatment Africa (PATA) and the United Nations Children’s Fund (UNICEF). Supported by View the full programme
View details View details
12 Jul 2027 - 15 Jul 2027
The 14th IAS Conference on HIV Science
IAS 2027, the 14th IAS Conference on HIV Science, will take place in Geneva, Switzerland, and virtually from 12 to 15 July 2027.
View details View detailsPast events
Getting to the Heart of Stigma Pre-conference
This pre-conference is a thought-leadership symposium seeking to present, discuss and interrogate the state-of-the-field evidence base for HIV-related stigma. It will be a platform to discuss global financial, strategic and programmatic efforts to contextualize, implement and scale up effective stigma reduction and mitigation interventions.
View details View detailsReflections on the COVID-19 pandemic and its application to the HIV response in West and Central Africa
IAS – the International AIDS Society – and APIN Public Health Initiatives are pleased to invite you to a regional scientific symposium, “Reflections on the COVID-19 pandemic and its application to the HIV response in West and Central Africa”.
Speakers and participants will discuss the following key and pressing topics for the region:
View details View detailsResearch priorities for an HIV cure: IAS Global Scientific Strategy
An HIV cure is a high priority for people living with HIV and an essential tool for the HIV response; a curative intervention could overcome the limitations of antiretroviral therapy (ART), limit new HIV transmissions, reduce stigma and discrimination, and provide a sustainable financial solution for epidemic control. IAS – the International AIDS Society – convened a 68-member International Scientific Working Group to develop the third Global Scientific Strategy, published in Nature Medicine in December 2021.
View details View details